News

PRESS RELEASE ON CEPHALEXIN 500
30.03.2023
PRESS RELEASE ON CEPHALEXIN 500
CUU LONG PHARMACEUTICAL JOINT STOCK COMPANY CONFIRMS NOT PRODUCING AND DISTRIBUTING CEPHALEXIN 500 HARD CAPSULES, BATCH NO. 04310322, NSX: 310322, HD: 310325, VD-25166-17 SAMPLED AT NGOC THANH THANH PHARMACY (GROUP 3, TAN LOI, TAN QUOI, BINH TAN, VINH LONG) Recently, upon receiving information and requests from relevant authorities regarding the above-mentioned drug sample, Cuu Long […]
Tập đoàn F.I.T công bố bộ nhận diện thương hiệu mới
09.03.2023
Tập đoàn F.I.T công bố bộ nhận diện thương hiệu mới
Cuu Long Pharmaceutical Financial Report 2022: A bright picture with record figures
22.02.2023
Cuu Long Pharmaceutical Financial Report 2022: A bright picture with record figures
F.I.T Group awards up to VND 10 billion to outstanding individuals and collectives in 2022
20.02.2023
F.I.T Group awards up to VND 10 billion to outstanding individuals and collectives in 2022
THE PHOTO CONTEST “F.I.T – WHERE I AM PROUD OF”
16.02.2023
THE PHOTO CONTEST “F.I.T – WHERE I AM PROUD OF”
CONSUMERS ARE RECOMMENDED TO BUY CEFIXIM 200MG AT GENUINE DISTRIBUTION SYSTEMS TO AVOID COUNTERFEITS AND KNOCKOFFS
11.02.2023
CONSUMERS ARE RECOMMENDED TO BUY CEFIXIM 200MG AT GENUINE DISTRIBUTION SYSTEMS TO AVOID COUNTERFEITS AND KNOCKOFFS
CONSUMERS ARE RECOMMENDED TO BUY CEFIXIM 200MG AT GENUINE DISTRIBUTION SYSTEMS TO AVOID COUNTERFEITS AND KNOCKOFFS To avoid buying unqualified drugs, Cuu Long Pharmaceutical Joint Stock Company recommends that customers should buy drugs at the Company’s distribution systems nationwide. Cuu Long Pharmaceutical recommends consumers to buy Cefixim 200mg at the genuine distribution systems. On February […]
OGSM Roll Out 2023: F.I.T Group transforms itself to reach futher
06.01.2023
OGSM Roll Out 2023: F.I.T Group transforms itself to reach futher
On January 6, 2023, F.I.T Group successfully organized the OGSM Roll Out 2023 conference. This was the most important event in the annual series of events taking place at the Group and its member companies at the end of December 2022 and the beginning of January 2023. OGSM is a key corporate governance tool, applied […]
Cuu Long Pharmaceutical achieved revenue exceeding VND 1,000 billion for the first time
03.01.2023
Cuu Long Pharmaceutical achieved revenue exceeding VND 1,000 billion for the first time
In 2022, Cuu Long Pharmaceutical Joint Stock Company (Cuu Long Pharmaceutical, stock code DCL) achieved VND 1,016 billion in revenue, equivalent to 144% over the same period last year. This is the highest revenue of the Company during 46 years of operation. Accordingly, information from Cuu Long Pharmaceutical said that in 2022, the Company was […]
Cuu Long Pharmaceutical participated in the Annual Scientific and Technical Conference 2022 at An Giang Central General Hospital
16.12.2022
Cuu Long Pharmaceutical participated in the Annual Scientific and Technical Conference 2022 at An Giang Central General Hospital
On the morning of December 10, 2022, Cuu Long Pharmaceutical Joint Stock Company attended the 2022 Annual Scientific and Technical Conference held at An Giang Central General Hospital. This year’s scientific and technical conference took place with a plenary session and two blocks of Internal Medicine and Surgery – Nursing. There were more than 300 […]